Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06293651 · RECRUITING
Trial details
- NCT number
- NCT06293651
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-18
- Primary completion
- 2026-01-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.